Arhus, Denmark
Joined June 2017
- Tweets179
- Following101
- Followers676
- Likes396
Herman’s large footprint have marked radiation oncology forever
Congratulation with the honor Michael
Jens Overgaard retweeted
Fantastic to see the Jens Overgaard award go to my good friend and mentor David Thwaites. An incredible achievement of work presented 🤓 #ESTRO2024 #DAHANCA35 #DAHANCA 🇩🇰💪🏴
Jens Overgaard retweeted
Great study by @j_grau_eriksen at @oncaarhus on unilateral treatment. Showing that the risk of contra lateral N-site recurrence is very low (1.2%). 💪#DAHANCA 🇩🇰 #ESTRO24
Jens Overgaard retweeted
1/ Next up NARLA2 #LUNGCANCER trial at #ESTRO24🔥🔥🔥
PET guided dose escalation phase III (because 60-66 Gy is not high enough for many tunors‼️)
Jens Overgaard retweeted
2/ NARLA2 at #ESTRO24
Early local control improved with dose escalarion ‼️
(As some ofbuse would expect😎)
No increase in toxicity
Survival data yet to come 🔥🔥🔥
Jens Overgaard retweeted
The #DAHANCA group on the big stage at #ESTRO24. Ruta presented the influence of GTV-CTV margin on dysphagia risk at 6 and 12 m. Next step is a prospective trial with 0 vs 5 mm margin #DAHANCA41 🇩🇰💪
Briterne har forstået det!
Mens vi fodslæbende i årevis småsnakker om at hæve prisen på en pakke smøger til 100 kr, har man i UK fattet at det eneste ansvarlige er at fjerne tobak fra kommende generationer - vi har stadig 15000+ tobaksdødsfald i DK hvert år.
Kom så med det forbud
We have - dahanca 30 (>1500 pts sofar)- to evaluate the importance of a hypoxic biomarker profile in rutine clinical setting (and a prematurely closed - due to poor recruting - international trial with eortc /da 29)
Indeed - hypoxia has always been adored in the lab - and ignored in the clinical. But anyone has an opinion about it - also without looking at the data. Hypoxia is not of importance in all tumors - but crucual in some, especialy squamous cell carcinomas.
